RxDoctor Payments Data

Glenn Kotz, MD

Family Medicine · Basalt, CONPI 1417943366

Payments from drug & device makers

$2,613in general payments, 2019–2025

Across 105 payments — averaging $24.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$562
  • Merck$500
  • Johnson & Johnson$263
  • Amgen$227
  • Pfizer$173
  • GSK$135
  • plus $752 from 24 others

What the payments were for

  • Consulting fees$50019%
  • Food & beverage$2,11381%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,613 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$312,865
Medicare patients
408
Services billed
5,511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban54$70,010
ForteoTeriparatide13$54,217
TymlosAbaloparatide15$38,865
XareltoRivaroxaban42$38,134
JardianceEmpagliflozin28$32,076
OzempicSemaglutide26$31,180
FarxigaDapagliflozin Propanediol21$25,279
MounjaroTirzepatide15$21,472
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$16,326
RytaryCarbidopa/Levodopa27$13,971
Buprenorphine16$4,920
Lisdexamfetamine Dimesylate12$3,855
Atorvastatin Calcium390$3,382
Rosuvastatin Calcium263$3,320
Gabapentin62$2,594

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$173$70,01054 claims
Johnson & JohnsonXarelto$263$38,13442 claims
Novo NordiskOzempic$76$31,18026 claims
AstraZenecaFarxiga$85$25,27921 claims
GSKTrelegy Ellipta$135$16,32616 claims
AbbVieSynthroid$562$89017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Basalt

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →